AU2002211536A1 - Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals - Google Patents

Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals

Info

Publication number
AU2002211536A1
AU2002211536A1 AU2002211536A AU1153602A AU2002211536A1 AU 2002211536 A1 AU2002211536 A1 AU 2002211536A1 AU 2002211536 A AU2002211536 A AU 2002211536A AU 1153602 A AU1153602 A AU 1153602A AU 2002211536 A1 AU2002211536 A1 AU 2002211536A1
Authority
AU
Australia
Prior art keywords
inflammation
humans
animals
compositions
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211536A
Inventor
Dusan Ninkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VAN BEEK RON
Original Assignee
VAN BEEK RON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VAN BEEK RON filed Critical VAN BEEK RON
Publication of AU2002211536A1 publication Critical patent/AU2002211536A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002211536A 2000-10-06 2001-10-09 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals Abandoned AU2002211536A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US23850100P 2000-10-06 2000-10-06
US60/238,501 2000-10-06
US24715700P 2000-11-10 2000-11-10
US60/247,157 2000-11-10
US27712101P 2001-03-19 2001-03-19
US60/277,121 2001-03-19
US28853101P 2001-05-03 2001-05-03
US60/288,531 2001-05-03
PCT/US2001/031483 WO2002028382A1 (en) 2000-10-06 2001-10-09 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals

Publications (1)

Publication Number Publication Date
AU2002211536A1 true AU2002211536A1 (en) 2002-04-15

Family

ID=27499925

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211536A Abandoned AU2002211536A1 (en) 2000-10-06 2001-10-09 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals

Country Status (3)

Country Link
US (1) US20020103261A1 (en)
AU (1) AU2002211536A1 (en)
WO (1) WO2002028382A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020119168A1 (en) * 2001-02-20 2002-08-29 Rudnic Edward M. Therapeutic agent delivery
US6586477B1 (en) 2002-10-31 2003-07-01 Sporicidin Company Teat dip composition containing phenol and phenate
JP2006528189A (en) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション Antibiotic products, their use and formulation
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528190A (en) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション Antibiotic preparations, their use and preparation
JP2007502296A (en) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006120494A1 (en) * 2005-05-13 2006-11-16 Advanced Scientific Developements Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2009037262A2 (en) * 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
US12034485B1 (en) * 2021-07-13 2024-07-09 Cisco Technology, Inc. Coherent optical breakout

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69726143T2 (en) * 1997-09-30 2004-07-22 D & W Trading B.V. Use of pharmaceutical compositions containing thymol and / or carvacrol in the treatment of histomoniasis
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
EP1353552B1 (en) * 2001-01-23 2007-02-28 Van Beek Global, LLC Pesticidal compounds and compositions

Also Published As

Publication number Publication date
WO2002028382A9 (en) 2003-02-13
US20020103261A1 (en) 2002-08-01
WO2002028382A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2002211536A1 (en) Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
AU2002329990A1 (en) Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
BR0207930A (en) Masked flavor liquid pharmaceutical compositions
CA2334267A1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
EP1600168A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder
EP1689348A4 (en) Oligosaccharide compositions and use thereof in the treatment of infection
DE60003803D1 (en) DRY MOLDABLE MEDICINAL FORMULATION
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
CA2401191A1 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
HUP0302925A3 (en) Amino-substituted tetracyclic compouds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
IL164973A (en) N-hydroxy formamide compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating bacterial infections
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of ***e dependency
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
WO2001085188A3 (en) Use of echinacea as a hematinic agent
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
ES2185310T3 (en) HERBAL ANTIVIRICAL AGENT.
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
WO2002000839A3 (en) Statement as to federally sponsored research
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer